drugset / Trial / NCT07272330

A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects

NCT07272330

Phase 1 Completed 38 enrolled Shandong Suncadia Medicine Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This Phase I clinical trial will investigate the relative bioavailability between two formulations of HRS-1893 tablets and the influence of food on the drug's pharmacokinetics in healthy adult participants. The safety and tolerability of HRS-1893 will also be monitored.

Timeline

Start
2025-12-11
Primary completion
2026-03-21
Completion
2026-03-21

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-1893 Unknown

Indications